Ownership history in Second Line Capital, LLC · 7 quarters on record
This page tracks every 13F SEC filing in which Second Line Capital, LLC reported a position in OCULAR THERAPEUTIX INC (OCUL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 500,746 | +98,279 | +24.4% | 1.25% | $6.1M | $12.14 |
| 2025 Q3 | ADDED | 402,467 | +17,000 | +4.4% | 0.97% | $4.7M | $11.69 |
| 2025 Q2 | ADDED | 385,467 | +39,369 | +11.4% | 0.83% | $3.6M | $9.28 |
| 2025 Q1 | ADDED | 346,098 | +6,000 | +1.8% | 0.65% | $2.5M | $7.33 |
| 2024 Q4 | ADDED | 340,098 | +77,288 | +29.4% | 0.78% | $2.9M | $8.54 |
| 2024 Q3 | UNCHANGED | 262,810 | — | 0% | 0.62% | $2.3M | $8.70 |
| 2024 Q2 | INITIATED | 262,810 | — | — | 0.55% | $1.8M | — |
As of 2025 Q4 — sorted by position size